Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in chronic low back pain
NCT00393211Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2000
- Primary completion
- Nov 2000
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in chronic low back pain (CLBP) (3 arms), sponsored by Organon & Co. Primary endpoint: Low back pain intensity scale (VAS) at 4 weeks. Started Apr 2000; status: completed.
02
Drugs
etoricoxib
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00393211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00393211.